Phillip Gerk, Pharm.D., Ph.D., is an expert in the biopharmaceutics and pharmacokinetics of opioids, natural compounds, and ketogenic molecules, with a particular focus on enhancing oral bioavailability. His work encompasses formulation, delivery, bioanalytical techniques, in vitro and in vivo pharmacokinetic disposition, drug delivery mechanics, compound stability, metabolism, and tissue penetration.
In his lab, advanced techniques and models are employed for drug transport, metabolism, and pharmacokinetics research. These include transcellular drug transport models, cell culture and assays, phase 1 and phase 2 drug metabolism assays, pharmacokinetic modeling, and various biopharmaceutical analytical techniques such as HPLC and mass spectrometry. His research has also explored potential synergies between compounds.
Gerk has filed four international patent applications, several provisional patents, and holds one issued patent.
Phillip Gerk, Pharm.D., Ph.D., is knowledgeable regarding the relevant details regarding the biopharmaceutics and pharmacokinetics of opioids, natural compounds, and ketogenic molecules for potential therapeutic applications, especially in regard to oral bioavailability enhancement. This includes focus on the formulation, delivery bioanalytical techniques, in vitro and in vivo pharmacokinetic disposition, drug delivery mechanics, compound stability, metabolism, and tissue penetration of these molecules. The techniques and models used in drug transport, metabolism, and pharmacokinetics research available in Gerk's lab and available for these research projects include transcellular drug transport models, cell culture and cell assays, phase 1 and phase 2 drug metabolism assays, pharmacokinetic modelling, and various biopharmaceutical analytical capabilities including HPLC and mass spectrometry. Gerk's lab has also investigated the potential for synergy. Gerk has filed four international patent applications and several provisional patents, and has one issued patent.
Ph.D. (Clinical Pharmaceutical Sciences), University of Kentucky, 2000
Pharm.D. (Pharmacy), University of Illinois at Chicago, 1993
Postgraduate Training
Post-Doctoral Scholar/Fellow (University of Kentucky, Graduate Center for Toxicology), 2000-2004
Clinical Research Fellow (Auburn University School of Pharmacy), 1993-1995
